Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-01-31

FDA Approved: HETLIOZ — Original Application (Vanda Pharmaceuticals Inc.)

View source ↗

Summary

The FDA granted original approval for Hetlioz (tasimelteon) from Vanda Pharmaceuticals for non-24-hour sleep-wake disorder, a circadian rhythm sleep disorder pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hetlioz (tasimelteon)

Snippet

ORIG AP for HETLIOZ (TASIMELTEON)